Saturday, February 21, 2026
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
  • My Account
  • Log In
Daily Remedy
  • Home
  • Articles
  • Podcasts
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    July 1, 2025

    The cost structure of hospitals nearly doubles

    July 1, 2025
    Navigating the Medical Licensing Maze

    The Fight Against Healthcare Fraud: Dr. Rafai’s Story

    April 8, 2025
  • Surveys

    Surveys

    How Confident Are You in RFK Jr.’s Health Leadership?

    How Confident Are You in RFK Jr.’s Health Leadership?

    February 16, 2026
    AI in Healthcare Decision-Making

    AI in Healthcare Decision-Making

    February 1, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    July 1, 2025

    The cost structure of hospitals nearly doubles

    July 1, 2025
    Navigating the Medical Licensing Maze

    The Fight Against Healthcare Fraud: Dr. Rafai’s Story

    April 8, 2025
  • Surveys

    Surveys

    How Confident Are You in RFK Jr.’s Health Leadership?

    How Confident Are You in RFK Jr.’s Health Leadership?

    February 16, 2026
    AI in Healthcare Decision-Making

    AI in Healthcare Decision-Making

    February 1, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Innovations & Investing

AI at the Bedside: The Quiet Revolution of Agentic Intelligence in Healthcare

As hospitals quietly pilot agentic AI and quantum computing, the healthcare industry faces an existential reflection on humanism and technology.

Ashley Rodgers by Ashley Rodgers
June 16, 2025
in Innovations & Investing
0

The surgical theater has always been humanity’s most intimate battleground against illness—a sacred arena where human skill meets nature’s uncertainty. Yet today, another force quietly reshapes the landscape: Agentic Artificial Intelligence (AI). These sophisticated autonomous agents, combined with quantum computing and remote surgical tools, are emerging from the shadows, revolutionizing hospitals with capabilities previously reserved for science fiction. But as technology rushes ahead, a vital, reflective question lingers: What would the great humanists like Sir William Osler or Ralph Waldo Emerson say about the soul of healthcare as it surrenders its scalpel to the silicon intellect?

AI on Autopilot: Understanding Agentic Intelligence

Agentic AI refers to advanced systems designed to autonomously make decisions and execute complex tasks without direct human oversight. Unlike traditional AI, which operates within strict guidelines provided by humans, agentic AI learns from its environment, continually adjusting and optimizing its responses based on outcomes. Its growing application in healthcare spans diagnostic assistance, surgical precision, patient management, and even nuanced patient interaction.

One notable example is at Johns Hopkins Medicine, where pilot projects are already underway involving agentic AI to assist surgeons in real-time decision-making during complex operations. These systems dynamically evaluate massive datasets—such as medical histories, real-time biometric data, and predictive outcomes—to guide precise surgical interventions.

Quantum computing, meanwhile, offers another technological leap, dramatically enhancing the speed and accuracy of data processing essential for real-time clinical decisions. IBM’s Quantum Network recently partnered with the Cleveland Clinic to harness quantum computing in clinical research and precision medicine, demonstrating quantum’s promise to revolutionize healthcare informatics.

Remote Surgery: Scalpel in the Cloud

Further augmenting agentic AI’s transformative potential is the rise of remote surgery—technology that allows surgeons to operate from a distance through robotic interfaces. Systems such as Intuitive Surgical’s da Vinci platform have paved the way, but integration with agentic AI could significantly enhance the surgeon’s capabilities. These sophisticated remote-operating-room tools not only increase surgical precision but also enable expertise to transcend geographical barriers, effectively democratizing advanced healthcare globally.

For instance, Mayo Clinic’s recent pilot with agentic AI-powered remote surgery technology showed significant reductions in surgical errors and improved postoperative outcomes. These breakthroughs hint at a future where geographic limitations no longer dictate the quality of surgical care.

Humanism at Crossroads: Emerson, Osler, and the AI Conundrum

Despite these advancements, healthcare remains at its core a deeply human endeavor, driven as much by empathy and understanding as by technical expertise. The towering figure of Sir William Osler, the father of modern clinical medicine, emphasized that medicine is inherently personal, urging doctors to “care more particularly for the individual patient than for the special features of the disease.” Similarly, Ralph Waldo Emerson championed humanistic wisdom, reminding us, “The first wealth is health.”

Would Osler and Emerson embrace or caution against this accelerating AI integration? They might marvel at the technology’s power to elevate clinical outcomes, yet simultaneously voice concerns over diminishing direct human engagement. How, they might rhetorically ask, does one preserve the sacred physician-patient relationship when the therapeutic touch risks replacement by algorithmic directives?

Balancing Act: AI and the Human Touch

Indeed, the concern is not unfounded. Healthcare’s intrinsic value extends beyond measurable outcomes to include compassion, emotional support, and understanding. The rise of agentic AI challenges practitioners to strike a delicate balance. Already, critics caution against the risks of over-reliance on automated systems, which might erode essential human interactions that comfort and heal.

However, advocates point to AI’s potential to enhance human capabilities, not replace them. Agentic AI could significantly reduce administrative burdens on healthcare providers, allowing doctors more time for patient interactions. Systems that intelligently handle routine procedures or monitoring could let clinicians focus on empathy-driven care, reinforcing, rather than undermining, the human element.

This approach aligns with a philosophy increasingly termed “augmented humanism”—leveraging technology not as a substitute but as a powerful adjunct to humanistic care.

Real-World Integration and Ethical Considerations

Early adopters like Stanford Health Care and Massachusetts General Hospital are mindful of these considerations. Stanford Health Care’s AI Health program consciously integrates AI tools while ensuring that humans remain central decision-makers. Massachusetts General Hospital, meanwhile, emphasizes ethical considerations in AI deployment, fostering dialogues about patient autonomy, informed consent, and algorithmic transparency.

Ethical oversight remains paramount. AI’s predictive capabilities raise privacy concerns, while decision-making autonomy sparks debates about accountability and transparency. Rigorous ethical frameworks must evolve concurrently with technological advances, ensuring responsible implementation.

Agentic AI’s Transformative Trajectory: Promise and Caution

As healthcare facilities worldwide explore agentic AI, quantum computing, and remote surgery, the opportunities appear boundless. Patient outcomes are improving, healthcare accessibility is expanding, and surgical precision has reached unprecedented heights.

Yet, this quiet revolution prompts healthcare to revisit its foundational values. The emergence of agentic AI compels clinicians and policymakers to continually reflect: How do we preserve the essential human elements of compassion and empathy in medicine as our tools grow ever more sophisticated?

ShareTweet
Ashley Rodgers

Ashley Rodgers

Ashley Rodgers is a writer specializing in health, wellness, and policy, bringing a thoughtful and evidence-based voice to critical issues.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

This conversation focuses on debunking myths surrounding GLP-1 medications, particularly the misinformation about their association with pancreatic cancer. The speaker emphasizes the importance of understanding clinical study designs, especially the distinction between observational studies and randomized controlled trials. The discussion highlights the need for patients to critically evaluate the sources of information regarding medication side effects and to empower themselves in their healthcare decisions.

Takeaways
GLP-1 medications are not linked to pancreatic cancer.
Peer-reviewed studies debunk misinformation about GLP-1s.
Anecdotal evidence is not reliable for general conclusions.
Observational studies have limitations in generalizability.
Understanding study design is crucial for evaluating claims.
Symptoms should be discussed in the context of clinical conditions.
Not all side effects reported are relevant to every patient.
Observational studies can provide valuable insights but are context-specific.
Patients should critically assess the relevance of studies to their own experiences.
Engagement in discussions about specific studies can enhance understanding

Chapters
00:00
Debunking GLP-1 Medication Myths
02:56
Understanding Clinical Study Designs
05:54
The Role of Observational Studies in Healthcare
Debunking Myths About GLP-1 Medications
YouTube Video DM9Do_V6_sU
Subscribe

2027 Medicare Advantage & Part D Advance Notice

Clinical Reads

BIIB080 in Mild Alzheimer’s Disease: What a Phase 1b Exploratory Clinical Analysis Can—and Cannot—Tell Us

BIIB080 in Mild Alzheimer’s Disease: What a Phase 1b Exploratory Clinical Analysis Can—and Cannot—Tell Us

by Daily Remedy
February 15, 2026
0

Can lowering tau biology translate into a clinically meaningful slowing of decline in people with early symptomatic Alzheimer’s disease? That is the practical question behind BIIB080, an intrathecal antisense therapy designed to reduce production of tau protein by targeting the tau gene transcript. In a phase 1b program originally designed for safety and dosing, investigators later examined cognitive, functional, and global outcomes as exploratory endpoints. The clinical question matters because current disease-modifying options primarily target amyloid, while tau pathology tracks...

Read more

Join Our Newsletter!

Twitter Updates

Tweets by TheDailyRemedy

Popular

  • The Prevention Gap in Dementia Care

    The Prevention Gap in Dementia Care

    0 shares
    Share 0 Tweet 0
  • Healthcare in Space

    1 shares
    Share 0 Tweet 0
  • Healthcare Natural Rights

    0 shares
    Share 0 Tweet 0
  • Heat Safety Tips Every Pregnant Mother Should Know

    0 shares
    Share 0 Tweet 0
  • What is the 411 on the New 988 Hotline?

    0 shares
    Share 0 Tweet 0
  • 628 Followers

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Join Our Newsletter!

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2026 Daily Remedy

No Result
View All Result
  • Home
  • Articles
  • Podcasts
  • Surveys
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner

© 2026 Daily Remedy